Korea United has launched its novel formulation of aceclofenac tablets, a move that facilitates competition in the domestic analgesic and anti-inflammatory markets.
The drug, called Clanza CR tablet, is characterized by rapid and sustained release profile of drug with once-daily regimen.
The company said it took ten years to develop the novel formulation at its own synthesis technology an...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.